We are live on ! Find out more
AIM

Alphinity Investment Management Portfolio holdings

AUM $6.01B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-8.45%
1 Year Est. Return
+37.17%
3 Year Est. Return
+151.02%
5 Year Est. Return
+235%
10 Year Est. Return
AUM
$448M
AUM Growth
-$76.5M
Cap. Flow
-$35.4M
Cap. Flow %
-7.9%
Top 10 Hldgs %
54.4%
Holding
32
New
5
Increased
9
Reduced
5
Closed
9

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$19.4M
2
MSFT icon
Microsoft
MSFT
+$19.1M
3
RGA icon
Reinsurance Group of America
RGA
+$15.2M
4
V icon
Visa
V
+$13.8M
5
MCD icon
McDonald's
MCD
+$13.4M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$31.8M
2
NOC icon
Northrop Grumman
NOC
+$22.4M
3
SPLK
Splunk Inc
SPLK
+$20.5M
4
TMO icon
Thermo Fisher Scientific
TMO
+$18.4M
5
T icon
AT&T
T
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 19.68%
2 Communication Services 16.41%
3 Financials 13.71%
4 Consumer Staples 13.02%
5 Technology 12.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
26
Micron Technology
MU
$835B
-224,255
Closed -$10.1M
NOC icon
27
Northrop Grumman
NOC
$76B
-70,504
Closed -$22.4M
PFE icon
28
Pfizer
PFE
$143B
-760,875
Closed -$31.8M
SPGI icon
29
S&P Global
SPGI
$124B
-66,200
Closed -$12.9M
T icon
30
AT&T
T
$164B
-556,419
Closed -$14.1M
TMO icon
31
Thermo Fisher Scientific
TMO
$214B
-75,525
Closed -$18.4M
SPLK
32
DELISTED
Splunk Inc
SPLK
-169,607
Closed -$20.5M

Similar funds

Alphinity Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Alphinity Investment Management held 32 positions worth $448M, down 15% from $525M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Alphinity Investment Management withdrew a net $35.4M in Q4 2018, closing 9 positions and reducing 5 holdings. Its most notable exit was Pfizer, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Alphinity Investment Management opened a new position in Bristol-Myers Squibb worth $18.8M.

  • Alphinity Investment Management's largest Q4 2018 buy was Bristol-Myers Squibb: 360,830 shares worth $18.8M.
  • Alphinity Investment Management added most to McDonald's in Q4 2018, an estimated $13.4M increase.
  • Alphinity Investment Management's biggest Q4 2018 reduction was Bank of America, cutting an estimated $4.05M.
  • Alphinity Investment Management fully exited Pfizer in Q4 2018, selling an estimated $31.8M.
  • Alphinity Investment Management's ten largest holdings make up 54% of its $448M portfolio in Q4 2018.
  • Alphinity Investment Management opened 5 new positions and closed 9 in Q4 2018.
  • Alphinity Investment Management's portfolio value fell 15% quarter-over-quarter to $448M.

Based on Alphinity Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.